Podcast: SLE researcher Professor Fabienne Mackay on being bold in medical research

Professor Fabienne Mackay of the University of Melbourne has worked for many years on what causes lupus and through that work the resulting medicine, belimumab, became the first ever targeted biological for the treatment of SLE patients with active, autoantibody-positive disease. In the latest episode of the university’s Eavesdrop on Experts podcasts she discusses the ...

Already a member?

Login to keep reading.

© 2021 the limbic